MILLENNIUM MANAGEMENT LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 84 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$52,743
+89294.9%
250,560
-32.6%
0.00%
Q1 2023$59
-88.1%
371,543
-58.3%
0.00%
Q4 2022$494
-100.0%
890,128
+5.8%
0.00%
-100.0%
Q3 2022$1,001,000
-15.5%
841,333
-55.1%
0.00%0.0%
Q2 2022$1,184,000
+1667.2%
1,872,423
+3106.1%
0.00%
Q1 2022$67,000
-96.0%
58,401
-92.1%
0.00%
-100.0%
Q4 2021$1,672,000
-83.4%
743,271
-74.8%
0.00%
-83.3%
Q3 2021$10,096,000
+10.8%
2,951,936
-3.2%
0.01%0.0%
Q2 2021$9,115,000
-12.2%
3,048,433
-5.2%
0.01%
-14.3%
Q1 2021$10,386,000
+460.5%
3,215,498
+267.9%
0.01%
+600.0%
Q4 2020$1,853,000
+4776.3%
873,954
+2618.0%
0.00%
Q3 2020$38,000
+65.2%
32,154
+25.4%
0.00%
Q2 2020$23,000
-89.2%
25,651
-77.4%
0.00%
Q1 2019$213,000
+159.8%
113,258
+62.3%
0.00%
Q4 2018$82,000
-68.0%
69,765
-26.0%
0.00%
Q3 2018$256,000
+21.9%
94,310
-14.4%
0.00%
Q2 2018$210,000
-69.4%
110,155
-66.4%
0.00%
-100.0%
Q1 2018$687,000
-71.8%
327,360
-72.7%
0.00%
-66.7%
Q4 2017$2,434,000
+213.3%
1,198,854
+105.3%
0.00%
+200.0%
Q3 2017$777,000
-38.5%
584,048
-27.4%
0.00%
-50.0%
Q2 2017$1,263,000
+43.5%
804,536
+195.4%
0.00%0.0%
Q1 2017$880,000
-20.7%
272,393
-66.9%
0.00%0.0%
Q4 2016$1,110,000
+360.6%
822,236
+432.7%
0.00%
Q3 2016$241,000
-74.6%
154,342
-78.4%
0.00%
-100.0%
Q2 2016$950,000
-77.5%
714,363
-10.7%
0.00%
-81.8%
Q1 2016$4,218,000
-63.1%
800,361
-45.0%
0.01%
-54.2%
Q4 2015$11,432,000
+642.8%
1,456,285
+699.8%
0.02%
+700.0%
Q3 2015$1,539,000
-69.2%
182,088
-60.1%
0.00%
-66.7%
Q2 2015$4,996,000
-59.9%
456,221
-48.8%
0.01%
-60.9%
Q1 2015$12,459,000
-40.6%
891,222
-28.2%
0.02%
-47.7%
Q4 2014$20,963,000
+29.2%
1,241,145
+2.7%
0.04%
+7.3%
Q3 2014$16,225,000
+170.4%
1,208,980
+156.7%
0.04%
+141.2%
Q2 2014$6,001,000
+4.7%
471,054
-2.3%
0.02%0.0%
Q1 2014$5,731,000
+14.8%
482,030
+33.4%
0.02%
+6.2%
Q4 2013$4,991,000
-69.1%
361,381
-61.0%
0.02%
-69.2%
Q3 2013$16,145,000
+794.5%
926,292
+731.0%
0.05%
+766.7%
Q2 2013$1,805,000111,4640.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders